Quantum BioPharma settles CAD 123,487 debt with 30,948 shares at CAD 3.99 each
QNTM•Debt settled with share issuance
Quantum BioPharma closed a debt settlement of CAD 123,487.43 through the issuance of 30,948 Class B subordinate voting shares.
The shares were issued at a deemed price of CAD 3.99, based on the prior CSE closing price.
The settlement covered amounts owed to arm’s-length creditors and insiders.
